Columbus Dispatch: Retail customers slowly return, but not all merchants benefit

UC economics professor Michael Jones predicts coronavirus worries will keep retail sales slow

The Columbus Dispatch turned to a prominent University of Cincinnati economist for insight into how the ongoing effects of the coronavirus pandemic will affect retail sales. 

Michael Jones, associate professor of economics with the UC Carl H. Lindner College of Business and executive director of the Kautz-Uible Economics Institute, told the Dispatch that cautious customer behaviours will cause sales to continue to slump, driven by fear of the ongoing pandemic.

portrait of Michael Jones

Michael Jones

Citing data released by Mastercard, Jones told the Dispatch that retail sales were down 15% in April and 5% in May. Restrictions on businesses imposed by the state of Ohio in an effort to slow the spread of the coronavirus have since been relaxed, but that doesn't mean customers are letting their guards down.

“Customers are starting to combine their trips,” to reduce the time spent outside their home, Jones told Dispatch reporter Patrick Cooley. “That reduces the likelihood that consumers will make an impulse purchase.”

Read the full story.

Featured Image: Lindner Hall, home of the Carl H. Lindner College of Business at the University of Cincinnati. Photo/Creative+Brand

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.

Related Stories

1

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.